A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ramucirumab when used in conjunction with
chemotherapy treatment can help participants with stomach, esophagus, and gastroesophageal
cancer.